AI-Assisted Molecular Review Refines SMO Inhibitor Candidacy in SHH Medulloblastoma
NEJM AI · 2026
DOI: 10.1056/aics2600997 ↗Kurz gefasst
Fallbericht in der Zeitschrift NEJM AI, 2026. Verfasst von Chen Buxbaum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neuro-Oncology Unit, Rambam Health Care Campus, Haifa, Israel. Hauptthemen laut MEDLINE: Medulloblastoma, Smoothened Receptor, Cerebellar Neoplasms, Hedgehog Proteins. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuro-Oncology Unit, Rambam Health Care Campus, Haifa, Israel.
- Department of Radiology, Rambam Health Care Campus, Haifa, Israel.
- Department of Pathology, Rambam Health Care Campus, Haifa, Israel.
- Hebrew University and Hadassah Medical School, Jerusalem, Israel.
ORCID-Profile: Chen Buxbaum, Anat Yahav-Dovrat, Yael Fisher, Haim Zilberman, Tali Siegal
Zitieren
APA
Buxbaum, C., Yahav-Dovrat, A., Fisher, Y., Zilberman, H., & Siegal, T. (2026). AI-Assisted Molecular Review Refines SMO Inhibitor Candidacy in SHH Medulloblastoma. NEJM AI. https://doi.org/10.1056/aics2600997
Vancouver
Buxbaum C, Yahav-Dovrat A, Fisher Y, Zilberman H, Siegal T. AI-Assisted Molecular Review Refines SMO Inhibitor Candidacy in SHH Medulloblastoma. NEJM AI. 2026. doi:10.1056/aics2600997
BibTeX
@article{Buxbaum2026,
author = {Buxbaum, Chen and Yahav-Dovrat, Anat and Fisher, Yael and Zilberman, Haim and Siegal, Tali},
title = {AI-Assisted Molecular Review Refines SMO Inhibitor Candidacy in SHH Medulloblastoma},
journal = {NEJM AI},
year = {2026},
doi = {10.1056/aics2600997}
}
EUVIMED